Clinical trials
Hemodialysis clinical trials
Below are recruiting hemodialysis clinical trials, each written for real people, not researchers. We’re tracking 153 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07506980Recruiting
Nurse-led program for dialysis patients to improve self-care
This study tests whether a nurse-led program can help people on dialysis improve their self-care and quality of life. It focuses on those who tend to gain fluid between sessions and may need extra support.
Gokarna, BagmatiAges 18–69 - NCT07016841Recruiting
Adding a filter to dialysis to clean your blood better
This study tests whether adding a special filter (hemoperfusion) to your regular hemodialysis can better remove waste products that build up in the blood. It might help people on dialysis feel better and have fewer complications.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07283926Enrolling by invitation
Restorative meals at home for older adults on dialysis
This trial tests if providing supportive meals at home can improve nutrition and health for older adults (60+) with chronic kidney disease who are on hemodialysis and from low-income, food-insecure households in Malaysia.
Kuala Lumpur, Kuala LumpurAges 60 years+ - NCT06906835Recruiting
Comparing two blood tests to guide iron treatment in dialysis patients
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
Pathumwan, BangkokAges 18–80 - NCT05874674Recruiting
Testing nafamostat to reduce bleeding risk during dialysis
This pilot study tests whether nafamostat is safe for people on hemodialysis who have a high risk of bleeding. It may help clinicians find safer ways to manage blood clotting medicines during dialysis.
Wŏnju, KangwondoAges 18–99 - NCT06520631Recruiting
Cryotherapy for pain from dialysis needle insertion
This study tests if applying cold therapy (cryotherapy) to the access site before needle insertion can reduce pain during hemodialysis. If you are on dialysis and have an arteriovenous fistula, this might help make your treatment more comfortable.
CairoAges 30–50 - NCT06794216Recruiting
Comparing dialysis methods to clean blood in kidney failure
This study compares different types of dialysis to see which removes waste products (uremic toxins) best from the blood. If you have been on dialysis for at least 6 months and use the same filter for a year, this trial may help find a better way to clean your blood.
Bologna, Emilia-RomagnaAges 18 years+ - NCT07746102Recruiting
Preconditioning therapy for chronic kidney disease patients
This study tests whether repeated brief periods of reduced blood flow (like a gentle squeeze on your arm) can improve how your body handles energy and blood flow. It is designed for people with any stage of chronic kidney disease (G1–G5).
LodzAges 18 years+ - NCT06708338Recruiting
Bevel direction during dialysis fistula puncture
This study looks at which way the needle bevel should face when starting dialysis through a new fistula. It might help reduce pain or damage to the fistula.
Le Puy-en-VelayAges 18–85 - NCT06329310Recruiting
Study of a new dialysis graft for kidney failure patients
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
LisbonAges 18 years+ - NCT04163614Recruiting
Testing blood pressure patterns and fluid removal during dialysis
This study looks at how blood pressure changes during hemodialysis and how much fluid is removed, to see what approach works best for controlling blood pressure. It may help dialysis patients whose blood pressure is often high before or after treatment.
Dallas, TexasAges 18 years+ - NCT03480568RecruitingPhase 3
A cholesterol injection study for people on dialysis
This study tests whether a cholesterol-lowering injection (alirocumab) helps people who are on regular dialysis. It aims to improve cholesterol control in a carefully selected group and tracks safety during treatment.
Dallas, TexasAges 18–80 - NCT03633708RecruitingPhase 3
Etelcalcetide for children with dialysis-related overactive parathyroid hormone
This trial studies etelcalcetide in children who have chronic kidney disease and too much parathyroid hormone while on hemodialysis. It aims to safely lower the hormone levels and help manage related bone/mineral problems.
Los Angeles, CaliforniaAges birth–18 years - NCT03969329RecruitingPhase 3
Etelcalcetide for children on dialysis with high parathyroid hormone
This Phase 3 trial tests etelcalcetide to lower a hormone called parathyroid hormone (PTH) in children who have kidney disease and secondary hyperparathyroidism while on hemodialysis. It may help control bone/mineral problems, but the study also checks heart rhythm safety and medication stability.
GhentAges 2–17 - NCT05117450Recruiting
Compare two dialysis membranes to adjust heparin use
This study compares two dialysis membranes while using a reduced “weaning” plan for the blood thinner heparin during hemodialysis. It aims to see which membrane works better and safely during routine chronic dialysis.
ReimsAges 18 years+ - NCT05410275RecruitingPhase 3
Low-dose rivaroxaban for dialysis patients without blood thinners
This study tests whether a lower dose of the blood thinner rivaroxaban is safe for people with kidney failure on dialysis who do not already need blood thinners. The goal is to find a way to prevent blood clots and strokes with less risk of bleeding.
ToursAges 18 years+ - NCT05612022Recruiting
Sound recording during hemodialysis fistula decisions
This study records and analyzes sounds from people getting hemodialysis through an access in the arm (an AV fistula or graft). It aims to see whether sound patterns can help assess or guide the best vascular access approach for dialysis.
Bergamo, BGAges 18–90 - NCT05786443RecruitingPhase 2
Empagliflozin test in adults on regular dialysis
This study tests whether the medicine empagliflozin is safe and helpful for adults who are on regular hemodialysis and still make a small amount of urine. The goal is to see if it can improve health outcomes while tracking side effects closely.
Boston, MassachusettsAges 18 years+ - NCT05884138Recruiting
Amino acid supplement and exercise for people on dialysis
This trial studies whether taking essential amino acids along with exercise can improve muscle function in people receiving hemodialysis. It may help you build or maintain strength and mobility.
Daejeon, South KoreaAges 20–80 - NCT05936710Recruiting
Citrate vs acetate dialysis to prevent low blood pressure
This study compares two types of dialysis fluid (citrate-based vs acetate-based) to see which better helps protect blood pressure during intermittent dialysis. It may help people in intensive care who are at risk of dialysis-related low blood pressure.
BéthuneAges 18 years+ - NCT05989659Recruiting
Transitioning to Home or In-Center Dialysis
This trial compares transitioning to home dialysis versus in-center dialysis for people with advanced kidney disease. It aims to find which option leads to better outcomes and quality of life.
Montreal, QuebecAges 18 years+ - NCT06001827Recruiting
Study of a wrap to help new dialysis access points heal
This trial tests a special wrap placed around a new arm access point for dialysis (called an AV fistula) to see if it helps the access stay healthy and work better. It is for people who need a new AV fistula for kidney dialysis.
Bullhead City, ArizonaAges 18 years+ - NCT06224140Recruiting
Dialysis without heparin: a safety study
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
Marseille, Bouches du RhôneAges 18 years+ - NCT06311240Recruiting
Chronic pain therapy in hemodialysis patients
This study looks at whether a certain kind of therapy can help people on dialysis who have chronic pain. If you have kidney failure and have been on hemodialysis for at least 3 months, you may be able to join.
Terrassa, BarcelonaAges 18 years+
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemodialysis?
- Yes. Clin2 currently lists 153 recruiting hemodialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemodialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemodialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.